114 | SYSTEMATIC INVESTIGATION OF DISEASE‐ AND GENOTYPE‐SPECIFIC VULNERABILITIES IN PRIMARY BLOOD CANCER USING HIGH‐THROUGHPUT EX VIVO DRUG SCREENING. - Hofer, K. D.; Scheinost, S.; Ben‐Taarit, L.; Hüllein, J.; Walther, T.; Putzker, K.; Sellner, L.; Kühn, M. W.; Kindler, T.; Nguyen‐Khac, F.; Maull, M. Crespo; Bosch, F.; et al. (Hematological oncology, 2025)